Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026

Option Care Health posts solid Q3 growth as it moves toward acquisition by CD&R and McKesson.

What the company is saying

Option Care Health reports third quarter 2026 net revenue of $1,493.5 million, a 4.1% increase year-over-year. The company highlights GAAP net income of $57.4 million, up 10.8%, and GAAP diluted EPS of $0.38, up 18.8%. Adjusted EBITDA reached $124.6 million, up 4.3%, and adjusted diluted EPS was $0.49, up 8.9%. Cash from operating activities for the quarter totaled $114.7 million. The company frames these results as evidence of continued operational and financial strength. It also announces a definitive merger agreement to be acquired by Clayton, Dubilier & Rice, LLC and McKesson Corporation. Due to the pending acquisition, Option Care Health has withdrawn its financial guidance and will not hold an earnings call for this quarter.

What the data suggests

The financial results show consistent year-over-year improvement across all major metrics for Q3 2026. Net revenue increased to $1,493.5 million, while GAAP net income rose to $57.4 million and diluted EPS to $0.38. Adjusted EBITDA of $124.6 million and adjusted diluted EPS of $0.49 both reflect solid operational performance. Cash provided by operating activities was $114.7 million for the quarter, and cash and cash equivalents stood at $299.1 million at quarter-end. Gross profit for Q3 was $284.97 million, with operating income of $89.2 million. The balance sheet remains strong, with total assets of $3,476.3 million and stockholders' equity of $1,324.5 million. The company’s withdrawal of guidance and absence of an earnings call signal a transition period as the acquisition process advances. No negative surprises or material weaknesses are disclosed in the financials.

Analysis

The announcement is a standard quarterly financial report, presenting realised and audited financial results for Q3 2026. All key claims—revenue, net income, EPS, adjusted EBITDA, cash flow, and balance sheet figures—are supported by disclosed numerical data. The only forward-looking elements are the withdrawal of guidance and the pending acquisition, both stated factually without promotional language or exaggerated projections. There is no narrative inflation or overstatement; the tone is neutral and factual, with no claims of future outperformance or synergies. The merger agreement is described as definitive, not aspirational, and no large capital outlay is paired with uncertain, long-dated returns. The benefits and results are immediate and measurable, with no hype or gap between narrative and evidence.

Risk flags

• ●The withdrawal of financial guidance and cancellation of the earnings call reduce transparency for investors during the acquisition process, limiting visibility into management's expectations and future performance.
• ●The pending acquisition by Clayton, Dubilier & Rice, LLC and McKesson Corporation introduces execution risk, including the possibility of regulatory delays, failure to obtain shareholder approval, or other closing conditions not being met.
• ●Operational risks remain during the transition, such as potential disruption to business activities, employee retention challenges, and customer or partner uncertainty as the company moves toward a change of control.
• ●The company’s balance sheet shows $1,151.1 million in long-term debt, which could affect post-acquisition capital structure and financial flexibility depending on transaction terms.

Bottom line

Option Care Health delivered another quarter of steady growth, with all key financial metrics improving year-over-year and cash generation remaining strong. The company is now in a transition phase due to its definitive merger agreement with Clayton, Dubilier & Rice and McKesson Corporation, which has led to the withdrawal of guidance and the suspension of earnings calls. While the financials show no red flags and the business appears stable, the acquisition process introduces new uncertainties, including regulatory approval and integration risks. Investors should expect limited near-term visibility into management’s outlook until the transaction closes. The most important takeaway is that Option Care Health’s core business remains healthy, but the investment thesis now hinges on the successful completion and terms of the pending acquisition.

Announcement summary

(NASDAQ:OPCH) Option Care Health, Inc. reported financial results for the third quarter ended September 30, 2026. Net revenue for the quarter was $1,493.5 million, representing an increase of 4.1% year-over-year. GAAP net income for the quarter was $57.4 million, up 10.8% from the prior year period. GAAP diluted earnings per share were $0.38, an increase of 18.8%. Adjusted EBITDA for the quarter was $124.6 million, up 4.3% year-over-year. Adjusted diluted earnings per share were $0.49, up 8.9%. Cash provided by operating activities in the third quarter was $114.7 million. The company has entered into a definitive merger agreement to be acquired by Clayton, Dubilier & Rice, LLC and McKesson Corporation. Due to the pending acquisition, Option Care Health will not host an earnings conference call for these results and has withdrawn its previously disclosed financial guidance. As of September 30, 2026, the company reported cash and cash equivalents of $299,093,000, accounts receivable (net) of $505,568,000, and inventories of $408,045,000. Total current assets were $1,312,091,000 and total noncurrent assets were $2,164,176,000, resulting in total assets of $3,476,267,000. Current liabilities were $850,530,000 and noncurrent liabilities were $1,301,259,000, for total liabilities of $2,151,789,000. Stockholders' equity was $1,324,478,000. For the three months ended September 30, 2026, gross profit was $284,974,000 and operating income was $89,216,000. Interest expense (net) for the quarter was $12,875,000. Income tax expense was $21,468,000. Weighted average shares outstanding, diluted, were 150,491,000 for the quarter. For the nine months ended September 30, 2026, net revenue was $4,286,583,000 and net income was $156,689,000. Net cash provided by operating activities for the nine months ended September 30, 2026, was $286,212,000. The company defines Adjusted EBITDA as net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses. Adjusted net income for the quarter was $74,391,000 and adjusted earnings per share, diluted, were $0.49. The company had over 8,000 team members, including more than 5,000 clinicians, as of the reporting date.

Disagree with this article?